Delivery Order SPE2DB20D3101-SPE2DB25FRUP1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,335.32 to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 MG tablets (60-count units). This competitively awarded, firm fixed-price delivery order was issued on June 6, 2025, with an ultimate completion date of June 9, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.19 to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count package). This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by June 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same city. This delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of 60 tablets of BRILINTA 90 mg at a firm fixed price of $10,575.36. This non-set-aside, competitively awarded contract is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $1,364.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of BRILINTA 60 mg tablets (60 count). The contract, with an ultimate completion date of July 30, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of BRILINTA 60 MG TABLET 60S with a potential value of $1,190.93. The contract has a completion date of March 5, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and holds an Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of BRILINTA 60 mg tablets. The firm-fixed-price contract, valued at $13,837.86, has an ultimate completion date of July 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a wide range of...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of BRILINTA 60 mg tablets. The contract has a completion date of January 29, 2024 and a potential value of $4,247.55. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is issued under a larger indefinite delivery contract (IDC) that...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,552.14 to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count packaging). This firm fixed-price, competitively awarded contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,534.28 for 60 mg Brilinta tablets (60-count) on August 27, 2025, with completion scheduled for August 28, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Brilinta 60 mg tablets in quantities of 60 units, with a contract ceiling value of $1,387.10. This competitively awarded, firm fixed-price delivery order is set to be completed by September 15, 2025, and represents fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUP1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,329.04 to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count packages). This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on September 5, 2025, with an ultimate completion date of September 8, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. As a primary pharmaceutical distributor for federal medical procurement, AmerisourceBergen leverages its comprehensive IDC vehicle to supply critical medications and medical supplies supporting Defense Health Agency operations and broader military healthcare systems. BRILINTA is an antiplatelet agent used for cardiovascular indications, consistent with the company's extensive portfolio of brand-name medications delivered across multiple therapeutic domains to federal customers. The firm fixed price structure and expedited completion timeline reflect the urgent nature of pharmaceutical resupply within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/5/25 |